GMED vs SKIN
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 18, 2026
GMED
SKIN
Investment Advisor Scores
SKIN
AI Analyst Insights
Detailed Metrics Comparison
| Metric | GMED | SKIN | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 18.797 | 106.383 | GMED |
| PEG Ratio | 1.7253 | 0.9262 | SKIN |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 5.9% | -7.8% | GMED |
| Earnings Growth | -26.2% | 0.0% | SKIN |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 35.5/100 | 59.3/100 | SKIN |
| Profit Margin | 17.0% | -9.8% | GMED |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | SELL | HOLD | SKIN |
Relative Price Performance (Last 90 Days)
Current Technical Phase
GMED
MarkupPrice above SMA50, rising 50-day trend (1.4% over 20 days), RSI 61
SKIN
NeutralMixed signals - no dominant trend phase, RSI 46
Fundamentals Snapshot
| Metric | GMED | SKIN |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 16.2 | 4.4 |
| Trailing P/E | 22.5 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | -0.1% |
| Gross Margin | 0.7% | 0.7% |
| Operating Margin | 0.2% | 0.0% |
| EPS | 3.80 | -0.24 |
| Dividend Yield | — | — |